| Dr David E Borgemenke, MD | |
|
2222 Philadelphia Dr, Dayton, OH 45406-1813 | |
| (937) 278-2612 | |
| Not Available |
| Full Name | Dr David E Borgemenke |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 35 Years |
| Location | 2222 Philadelphia Dr, Dayton, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144296906 | NPI | - | NPPES |
| 000000192031 | Other | OH | ANTHEM |
| 0791951 | Medicaid | OH | |
| 64042419 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 35060140B (Ohio) | Primary |
| 207L00000X | Anesthesiology | 0101047804 (Virginia) | Secondary |
| 207L00000X | Anesthesiology | 01043175A (Indiana) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atrium Medical Center | Franklin, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesiology Services Network Ltd | 8820902794 | 176 |
News Archive
Neuroscientists at Georgetown University Medical Center say they have developed and tested an agent that reduces the buildup of toxic proteins in animal models of both Parkinson's and Alzheimer's diseases, and improves cognitive and motor behavior.
BioTime, Inc. today announced a $4 million equity financing by its subsidiary, Embryome Sciences, Inc. Concurrent with the financing, Embryome Sciences will be renamed ReCyte Therapeutics, Inc. and will develop therapeutic products for cardiovascular and blood diseases. The new equity financing is being led by a $2.5 million investment by private investors and a $1.5 million investment from BioTime that valued ReCyte Therapeutics at a post money valuation of $60 million on a fully diluted basis.
The vast majority of pediatricians and family physicians nationally are offering the human papillomavirus (also called HPV) vaccine, though fewer physicians are strongly encouraging it for 11- to 12-year-old girls as recommended by national guidelines, according to a survey in the September issue of Pediatrics, the journal of the American Academy of Pediatrics.
"The promise of health care reform is that it will provide all Americans coverage, allow them to keep their coverage if they like it, and bends the cost curve to put the system on a sustainable path. These are the standards by which any reform bill should be judged, and the Senate bill falls short of meeting them. We believe that these issues can be addressed and improved to achieve these goals, and we will continue to work with policymakers toward that end.
› Verified 2 days ago
| Entity Name | Anesthesiology Services Network Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821076779 PECOS PAC ID: 8820902794 Enrollment ID: O20031114000467 |
News Archive
Neuroscientists at Georgetown University Medical Center say they have developed and tested an agent that reduces the buildup of toxic proteins in animal models of both Parkinson's and Alzheimer's diseases, and improves cognitive and motor behavior.
BioTime, Inc. today announced a $4 million equity financing by its subsidiary, Embryome Sciences, Inc. Concurrent with the financing, Embryome Sciences will be renamed ReCyte Therapeutics, Inc. and will develop therapeutic products for cardiovascular and blood diseases. The new equity financing is being led by a $2.5 million investment by private investors and a $1.5 million investment from BioTime that valued ReCyte Therapeutics at a post money valuation of $60 million on a fully diluted basis.
The vast majority of pediatricians and family physicians nationally are offering the human papillomavirus (also called HPV) vaccine, though fewer physicians are strongly encouraging it for 11- to 12-year-old girls as recommended by national guidelines, according to a survey in the September issue of Pediatrics, the journal of the American Academy of Pediatrics.
"The promise of health care reform is that it will provide all Americans coverage, allow them to keep their coverage if they like it, and bends the cost curve to put the system on a sustainable path. These are the standards by which any reform bill should be judged, and the Senate bill falls short of meeting them. We believe that these issues can be addressed and improved to achieve these goals, and we will continue to work with policymakers toward that end.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David E Borgemenke, MD Po Box 640446, Cincinnati, OH 45264-0001 Ph: (937) 293-0247 | Dr David E Borgemenke, MD 2222 Philadelphia Dr, Dayton, OH 45406-1813 Ph: (937) 278-2612 |
News Archive
Neuroscientists at Georgetown University Medical Center say they have developed and tested an agent that reduces the buildup of toxic proteins in animal models of both Parkinson's and Alzheimer's diseases, and improves cognitive and motor behavior.
BioTime, Inc. today announced a $4 million equity financing by its subsidiary, Embryome Sciences, Inc. Concurrent with the financing, Embryome Sciences will be renamed ReCyte Therapeutics, Inc. and will develop therapeutic products for cardiovascular and blood diseases. The new equity financing is being led by a $2.5 million investment by private investors and a $1.5 million investment from BioTime that valued ReCyte Therapeutics at a post money valuation of $60 million on a fully diluted basis.
The vast majority of pediatricians and family physicians nationally are offering the human papillomavirus (also called HPV) vaccine, though fewer physicians are strongly encouraging it for 11- to 12-year-old girls as recommended by national guidelines, according to a survey in the September issue of Pediatrics, the journal of the American Academy of Pediatrics.
"The promise of health care reform is that it will provide all Americans coverage, allow them to keep their coverage if they like it, and bends the cost curve to put the system on a sustainable path. These are the standards by which any reform bill should be judged, and the Senate bill falls short of meeting them. We believe that these issues can be addressed and improved to achieve these goals, and we will continue to work with policymakers toward that end.
› Verified 2 days ago
Sumiko S Sarle, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2222 Philadelphia Dr, Dayton, OH 45406 Phone: 937-278-2612 | |
Mr. Antonio M Licata, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Wyoming St, 3 Fl / Anes. Dept, Dayton, OH 45409 Phone: 937-208-4380 Fax: 937-208-3843 | |
Joseph Mulcare, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Wyoming St, Dayton, OH 45409 Phone: 937-208-6173 Fax: 937-208-3843 | |
Dr. Roberta Elizabeth Galford, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1997 Miamisburg Centerville Rd, Dayton, OH 45459 Phone: 937-401-6220 | |
Dr. Thomas James Fritz, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2222 Philadelphia Dr, Dayton, OH 45406 Phone: 937-278-2612 | |
Dr. Brian C Bane, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2222 Philadelphia Drive, Dayton, OH 45406 Phone: 937-278-1624 Fax: 937-567-4163 | |
Mark Chambers, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Wyoming St, 3rd Floor, Anesthesia Dept, Dayton, OH 45409 Phone: 937-208-2627 |